98%
921
2 minutes
20
Background: The incidence of cutaneous squamous cell carcinoma (cSCC) has been demonstrating yearly increases. cSCC is a malignant cancer and exerts a major impact on patients' health and quality of life. Thus, the development and use of novel therapies in the treatment of cSCC are needed. It has been reported that LED photodynamic therapy (LED PDT) mediated by Hypocrellin B and its derivatives, a second-generation photosensitizer, can induce apoptosis in a variety of tumor cells, However, its potential pro-apoptotic effects on cSCC have yet to be investigated.
Objective: This study aims to investigate the pro-apoptotic effects and molecular mechanisms of HB-LED PDT in cutaneous squamous cell carcinoma A431 cells (Subsequent abbreviation A431 cells). Such information can provide an important theoretical foundation for the clinical translation of HB-LED PDT in the treatment of cSCC.
Methods: 1. Effects of HB on A431 cells were determined using a Cell Counting Kit-8 assay, which method can indirectly reflect the number of living cells. In this way, this assay can then provide a means to identify the optimal concentrations of HB required for the induction of apoptosis in A431 cells. 2. The effects of HB-LED PDT on the morphology of A431 cells and changes in the nuclei after Hoechst33342 staining as determined using inverted fluorescent microscopy. 3. Use of the Annexin V-FITC test kit to detect levels of apoptosis in A431 cells in response to treatment with HB. Changes in reactive oxygen species and mitochondrial membrane potential following HB-LED PDT treatment in A431 cells were determined using fluorescence activated cell sorting (FACS). 4. Real-time quantitative PCR and Western Blot were applied to assess changes in several key factors involved in apoptosis including Bax, Bcl-2, and Caspase-3, at both transcription and translation levels. With these assays, it was possible to investigate the apoptotic signaling pathway in A431 cells in response to HB-LED PDT.
Results: HB-LED PDT inhibited proliferation activity and promoted nuclear fragmentation within these A431 cells. HB-LED PDT inhibited mitochondrial activity, increased reactive oxygen species production, and promoted apoptosis of A431 cells. In addition, several key factors in the apoptotic signaling pathway were increased at both the transcriptional and translational levels in A431 cells in response to the HB-LED PDT, indicating that the apoptotic signaling pathway was activated by HB-LED PDT.
Conclusion: HB-LED PDT induces apoptosis in A431 cells through a mitochondria-mediated apoptotic pathway. Such findings serve as an important foundation for the development of new approaches in the treatment of cSCC.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.pdpdt.2023.103683 | DOI Listing |
J Skin Cancer
August 2025
Department of Dermatology, University Medical Center Mannheim, Heidelberg University, Mannheim, Baden-Württemberg, Germany.
Corticotropin-releasing hormone (CRH) regulates immunological and cellular processes. Recently, CRH is expressed in skin cancers, where its expression appears to correlate with the degree of malignancy. This study correlates CRH expression in melanoma metastases with patient survival and compares the intensity of CRH expression in melanoma to that in less aggressive skin cancer entities.
View Article and Find Full Text PDFDrug Metab Rev
September 2025
Department of Chemistry, Faculty of Science, Sri Chandrasekharendra Saraswathi Viswa Mahavidyalaya (Deemed to be University) (SCSVMV), Kanchipuram, India.
This comprehensive review explores the therapeutic promise of cyclodextrin-grafted magnetite (FeO) nanocarriers in anticancer applications, focusing on their design, drug delivery mechanisms, biological stability, and therapeutic performance. Systems integrating cyclodextrins (cds) with FeO nanoparticles (FeO-cd-drug) have been developed for delivery of key anticancer agents such as docetaxel, irinotecan, paclitaxel, and doxorubicin across 11 cancer cell types. Results demonstrate up to 60% reduced cancer cell viability when using magnetite nanoparticle (FeO-np)-cds-docetaxel/irinotecan/doxorubicin systems compared to the pristine drug.
View Article and Find Full Text PDFColloids Surf B Biointerfaces
December 2025
Department of Biological and Chemical Physics of Polymers, Emanuel Institute of Biochemical Physics, Russian Academy of Sciences, Kosygina ul. 4, Moscow 119334, Russian Federation; Academic Department of Technology and Chemistry of Innovative Materials, Plekhanov University of Economics, Stremyanny
The study explores novel electrospun poly(3-hydroxybutyrate) (PHB) systems for pheophorbide derivative (PheoD) photosensitizers delivery in anticancer photodynamic therapy (PDT). The photophysical properties of PheoD within PHB matrix and the resulting impact on polymer morphology (SEM, AFM), supramolecular structure (XRD, EPR), mechanical behavior, in vitro release, cytotoxicity assay on A431 cells, and antimicrobial properties were investigated. It was shown, that the difference in the PheoD's radical does not affect PHB's semicrystalline nature and amorphous region's structure but causes significant changes in the morphological characteristics of the surface.
View Article and Find Full Text PDFPlants (Basel)
August 2025
Department of Biomedical Sciences, Chung Shan Medical University, Taichung City 402, Taiwan.
Carnivorous plants have garnered attention as sources of pharmacologically active compounds, yet their floral tissues remain largely underexplored. In this study, we investigated the bioactive properties of flower extracts prepared using water, methanol, ethanol, and acetone. Among these, the ethanol extract exhibited the highest total phenolic content (18.
View Article and Find Full Text PDFFront Immunol
August 2025
College of Biomedicine and Health, Huazhong Agricultural University, Wuhan, Hubei, China.
Introduction: B7-H6, a tumor-specific immune checkpoint molecule within the B7 family, represents a promising therapeutic target due to its selective overexpression in malignancies and negligible expression in normal tissues.
Method: Here, we developed bispecific antibodies (BsAbs) targeting B7-H6 to redirect T and NK cells against solid tumors. Through phage display, 15 high-affinity B7-H6 monoclonal antibodies were generated.